3 months ago
INSM
AnalystsJason ZemanskyJason Zemansky's Stock Forecasts
AnalystsJason Zemansky
Sectors:
Analyst Ranking
Top 8%
#407 out of 5020 analysts
Average Return
+32.35%
Win Rate
71%25 out of 35
Risk vs Reward
Poor
Good
Jason Zemansky's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Insmed IncINSM | +197.14% | $27.28 | $81.06 | 2024-02-22 - 2025-02-21 | Strong Buy |
Werewolf Therapeutics IncHOWL | +180.18% | $2.17 | $6.08 | 2023-03-22 - 2024-03-22 | Strong Buy |
Insmed IncINSM | +175.86% | $26.43 | $72.91 | 2023-09-05 - 2024-09-05 | Strong Buy |
Esperion Therapeutics IncESPR | +118.25% | $1.37 | $2.99 | 2023-06-14 - 2024-06-14 | Strong Buy |
Insmed IncINSM | +106.95% | $69.96 | $144.78 | 2024-10-08 - 2025-09-17 | Strong Buy |
Jason Zemansky Analyst Color
Get additional color on Jason Zemansky's coverage of popular stocks
6 months ago
INSM
a year ago
INSM
a year ago
TVTX
a year ago
TVTX
a year ago
SNDX
a year ago
INSM
a year ago
INSM
Jason Zemansky's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Werewolf Therapeutics IncHOWL | 5 | Strong Buy | $8.00 | +471.43% | Maintains | 24 days ago |
Rocket Pharmaceuticals IncRCKT | 2 | Strong Buy | $10.00 | +230.03% | Upgrades | a month ago |
Insmed IncINSM | 10 | Strong Buy | $109.00 | -24.71% | Maintains | 3 months ago |
Keros Therapeutics IncKROS | 2 | Hold | $18.00 | +15.24% | Downgrades | 3 months ago |
Cytokinetics IncCYTK | 4 | Hold | $54.00 | +13.54% | Maintains | 5 months ago |
Travere Therapeutics IncTVTX | 4 | Strong Buy | $31.00 | +31.08% | Maintains | 6 months ago |
Arcus Biosciences IncRCUS | 5 | Hold | $17.00 | +41.31% | Maintains | 7 months ago |
Kura Oncology IncKURA | 2 | Strong Buy | $29.00 | +258.47% | Maintains | 10 months ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $31.00 | N/A | Maintains | a year ago |
Esperion Therapeutics IncESPR | 5 | Sell | $2.50 | N/A | Downgrades | a year ago |
Kalaris Therapeutics IncKLRS | 2 | Sell | $23.00 | N/A | Downgrades | 2 years ago |
Onkure Therapeutics IncOKUR | 1 | Strong Buy | $230.00 | N/A | Initiates Coverage On | 2 years ago |
Q32 Bio IncQTTB | 1 | Strong Buy | $162.00 | N/A | Maintains | 4 years ago |
Allakos IncALLK | 1 | Strong Buy | $155.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.